Dr. Albert Friesen reports

MEDICURE TO PRESENT FINANCIAL RESULTS ON APRIL 29, 2025 CALL AT 8:30 AM ET FOR QUARTER AND YEAR ENDED DECEMBER 31, 2024

Medicure Inc. will present the 2024 year-end financial results via conference call on April 29, 2025, at 8:30 am Eastern Time. The 2024 year-end financials will be filed after market close on April 28, 2025.

You may request international country-specific access information by e-mailing the company in advance. Management will accept and answer questions related to the financial results and operations during the question-and-answer period at the end of the conference call. A recording of the call will be available following the event at the company's website.

About Medicure Inc.

Medicure is a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The present focus of the company is the marketing and distribution of Aggrastat (tirofiban hydrochloride) injection and Zypitamag (pitavastatin) tablets in the United States, where they are sold through the company's United States subsidiary, Medicure Pharma Inc. Medicure also operates Marley Drug Inc., a pharmacy subsidiary servicing all 50 states, Washington, D.C., and Puerto Rico. Marley Drug is committed to improving access to medications for all Americans together with exceptional customer service and free home delivery.

We seek Safe Harbor.